Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis
Malin Hagberg Thulin(Sahlgrenska University Hospital), Kristin Austlid Taskén(Oslo University Hospital)
Cited by 4
Related Papers
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
|Molecular Cancer|2011|93